Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques
NCT05088161 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2021-10-21
Summary
In this study, we will use high-throughput proteomics techniques to search for biomarkers of post-operative prognosis of pancreatic cancer in samples of patients who have been diagnosed with pancreatic cancer through bioinformatics analysis.
Conditions
- Patients
Sponsors & Collaborators
-
The Affiliated Hospital of Qingdao University
lead OTHER
Principal Investigators
-
Yu Cao, Doctor · the study director of phase I clinical research center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-13
- Primary Completion
- 2021-11-12
- Completion
- 2022-03-12
Countries
- China
Study Locations
More Related Trials
-
Identification of Biomarkers for Early Detection of Pancreatic Cancer
NCT00897494 ·Status: COMPLETED
-
Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy
NCT04241367 ·Status: COMPLETED
-
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
NCT01692873 ·Status: COMPLETED ·Phase: NA
-
The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic Cancer
NCT03076502 ·Status: UNKNOWN
-
Multi-omics Model for Pancreatic Cancer Screening Using cfDNA
NCT06456281 ·Status: RECRUITING
-
Tumour Regulatory Molecules in Early Pancreatic Cancer Detection
NCT03536793 ·Status: RECRUITING
-
A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy
NCT04281511 ·Status: COMPLETED
-
Early Detection of Pancreatic Cancer
NCT05596435 ·Status: UNKNOWN
-
Studying Biomarkers in Patients With Pancreatic Cancer
NCT00900003 ·Status: COMPLETED
-
Exploring the Mechanism of Severe Acute Pancreatitis Based on Metagenomics, Metabolomics and Proteomics
NCT06230432 ·Status: NOT_YET_RECRUITING
-
Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach
NCT06151691 ·Status: NOT_YET_RECRUITING
-
Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients
NCT06147154 ·Status: COMPLETED
-
Construction and Evaluation of China's Advanced Pancreatic Tumor Big Data Center
NCT05141656 ·Status: UNKNOWN
-
Project Survival-Prospective Biomarker Discovery
NCT02781012 ·Status: UNKNOWN
-
Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic Cancer
NCT04110769 ·Status: UNKNOWN ·Phase: NA
-
Optical and Biochemical Biomarkers in Early Pancreatic Cancer
NCT03404661 ·Status: COMPLETED
-
Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis
NCT06411470 ·Status: RECRUITING
-
The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer
NCT06873178 ·Status: ACTIVE_NOT_RECRUITING
-
The Development of a Metabolomic Test to Diagnose and Quantify Pancreatic Exocrine Insufficiency (The DETECTION Study)
NCT05980221 ·Status: UNKNOWN ·Phase: NA
-
AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort
NCT06638866 ·Status: RECRUITING
-
Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis
NCT02869802 ·Status: RECRUITING
-
Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer
NCT00559598 ·Status: COMPLETED
-
A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS
NCT05621824 ·Status: NOT_YET_RECRUITING
-
Multi-omics Characterization of Pancreatic Neuroendocrine Tumors and Carcinomas
NCT05234450 ·Status: UNKNOWN
-
Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer
NCT04536220 ·Status: RECRUITING